Molbio Diagnostics was incorporated on October 20, 2000. The company develops innovative point-of-care diagnostics through its patented ‘Truenat’ PCR platform, enabling rapid testing for 30+ diseases across 100+ countries. It also offers radiology, digital pathology, and breast health solutions while building a pipeline of new products